FORMOTEROL FUMARATE
Total Payments
$188,771
Transactions
12
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $188,771 | 12 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $188,771 | 12 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TV48107-COPD-10094 | Teva Pharmaceuticals USA, Inc. | $188,771 | 0 |
Top Doctors Receiving Payments for FORMOTEROL FUMARATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | North Dartmouth, MA | $188,771 | 12 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $188,771
Product Information
- Type Drug
- Total Payments $188,771
- Total Doctors 0
- Transactions 12
About FORMOTEROL FUMARATE
FORMOTEROL FUMARATE is a drug associated with $188,771 in payments to 0 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $188,771 was paid across 12 transactions to 0 doctors.
The most common payment nature for FORMOTEROL FUMARATE is "Unspecified" ($188,771, 100.0% of total).
FORMOTEROL FUMARATE is associated with 1 research study, including "TV48107-COPD-10094" ($188,771).